Postprandial Glucose and Triglyceride Increases Along with the Endothelial Malfunction were Attenuated by the Administration of SGLT2 Inhibitor, Empagliflozin

Saved in:

Bibliographic Details
Published in	Journal of Atherosclerosis and Thrombosis Vol. 27; no. 7; pp. 637 - 638
Main Authors	Masuda, Daisaku, Yamashita, Shizuya
Format	Journal Article
Language	English
Published	Japan Japan Atherosclerosis Society 01.07.2020
Subjects	Benzhydryl Compounds - administration & dosage Cardiometabolic Risk Factors Cardiovascular Diseases - prevention & control Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - metabolism Dyslipidemias - drug therapy Dyslipidemias - metabolism Endothelium, Vascular - drug effects Glucose - metabolism Glucosides - administration & dosage Humans Lipid Metabolism - drug effects Sodium-Glucose Transporter 2 Inhibitors - administration & dosage Triglycerides - blood
Online Access	Get full text
ISSN	1340-3478 1880-3873 1880-3873
DOI	10.5551/jat.ED124

More Information
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1
ISSN:	1340-3478 1880-3873 1880-3873
DOI:	10.5551/jat.ED124